Mallinckrodt plans to spin off specialty generics business

Share this post

Mallinckrodt Plc said on Thursday it planned to spin off its specialty generics business to shareholders by the second half of 2019, capping a two-year long effort to look for options for the unit.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply